Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
CME Group Inc Market Cap
Based on ratings from 18 stock analysts, the CME Group Inc stock price is expected to decrease by 1.18% in 12 months. This is calculated by using the average 12-month stock price forecast for CME Group Inc. The lowest target is $181 and the highest is $275. Please note analyst price targets are not guaranteed and could be missed completely.
About 18 Wall Street analysts have assignedCME 6 buy ratings, 9 hold ratings, and 3 sell ratings. This means that analysts expect CME Group Inc to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CME. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CME.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Brian Bedell Deutsche Bank | Hold | $226 | Maintains | Nov 11, 2024 |
| Patrick Moley Piper Sandler | Overweight | $250 | Maintains | Oct 28, 2024 |
| Benjamin Budish Barclays | Equal-Weight | $231 | Maintains | Oct 24, 2024 |
| Ashish Sabadra RBC Capital | Sector Perform | $235 | Reiterates | Oct 24, 2024 |
| Christopher Allen Citigroup | Buy | $255 | Maintains | Oct 24, 2024 |
| Owen Lau Oppenheimer | Outperform | $258 | Maintains | Oct 24, 2024 |
| Mike Cyprys Morgan Stanley | Equal-Weight | $233 | Maintains | Oct 17, 2024 |
| Owen Lau Oppenheimer | Outperform | $245 | Maintains | Oct 14, 2024 |
| Patrick Moley Piper Sandler | Overweight | $240 | Maintains | Oct 8, 2024 |
| Simon Clinch Redburn Atlantic | Neutral | $244 | Downgrade | Oct 8, 2024 |
| Benjamin Budish Barclays | Equal-Weight | $219 | Maintains | Oct 7, 2024 |
| Ashish Sabadra RBC Capital | Sector Perform | $235 | Reiterates | Oct 3, 2024 |
| Craig Siegenthaler B of A Securities | Underperform | $180 | Maintains | Oct 3, 2024 |
| Christopher Allen Citigroup | Buy | $250 | Maintains | Oct 3, 2024 |
| Alexander Blostein Goldman Sachs | Sell | $198 | Maintains | Oct 3, 2024 |
| Ashish Sabadra RBC Capital | Sector Perform | $235 | Initiates | Sep 27, 2024 |
| Bill Katz TD Cowen | Hold | $221 | Initiates | Sep 26, 2024 |
| Craig Siegenthaler B of A Securities | Underperform | $177 | Downgrade | Sep 3, 2024 |
| Patrick Moley Piper Sandler | Overweight | $225 | Reiterates | Aug 20, 2024 |
| Brian Bedell Deutsche Bank | Hold | $200 | Maintains | Aug 15, 2024 |
When did it IPO
2002
Staff Count
3,565
Country
United States
Sector/Industry
Financial Services/Financial Data & Stock Exchanges
CEO
Mr. Terrence A. Duffy
Market Cap
$86.26B
In 2023, CME generated $5.58B in revenue, which was a increase of 11.15% from the previous year. This can be seen as a signal that CME's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Thu, 05 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - CME Group's Board declared a 2024 annual variable dividend of $5.80 per share as part of initiatives to return capital to shareholders.
Why It Matters - CME Group's $5.80 annual variable dividend indicates strong financial health and a commitment to returning capital, potentially boosting investor confidence and share value.
Thu, 05 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - CME Group plans to launch a 1-Ounce Gold futures contract on January 13, 2025, pending regulatory approval, responding to increased retail interest in gold investments.
Why It Matters - The launch of a 1-Ounce Gold futures contract by CME Group signals increased retail interest in gold, potentially driving demand and impacting gold prices and related investments.
Wed, 04 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - CME Group launched CME Term €STR Reference Rates to address client demand for a term rate linked to €STR markets, using data from its €STR futures and OTC swaps.
Why It Matters - CME Group's introduction of Term €STR Reference Rates enhances market transparency and liquidity, potentially attracting more investors to €STR futures and OTC swaps.
Wed, 04 Dec 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - CME Group's strong global presence, diverse product portfolio, focus on over-the-counter clearing, and solid capital position indicate potential for growth.
Why It Matters - CME Group's strong global presence and focus on over-the-counter clearing indicate potential revenue growth, enhancing investor confidence in its future performance and stability.
Wed, 04 Dec 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - Two dividend stocks have been identified as strong picks for income and stability in the current uncertain market, poised for long-term growth despite challenges.
Why It Matters - Identifying dividend stocks that offer income and stability is crucial in uncertain markets, as they can provide resilience and potential growth during challenging economic conditions.
Tue, 03 Dec 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - CME Group reported a record November 2024 average daily volume of 30.2 million contracts, up 7% from November 2023, with notable increases in U.S. Treasury futures and options.
Why It Matters - Rising trading volumes in U.S. Treasury futures and other products indicate increased market activity and liquidity, suggesting heightened investor interest and potential volatility.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
